Search For "manufacturing organization"
LOTTE Biologics to Participate in DCAT Week 2026 in New York to Explore Gl
Updated : 2 months, 1 week ago IST
Seoul [South Korea], March 9: LOTTE Biologics announced today that it will participate in DCAT Week 2026, a global pharmaceutical and biotechnology industry event taking place in New York from March 23 to 26, to explore new partnership opportunities and strengthen its global presence in the
Read More
Morepen Bags Rs. 825 Crore Global Deal
Updated : 2 months, 1 week ago IST
Gurugram (Haryana) [India], February 23: Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has secured a multi-year Contract Development and Manufacturing Organization (CDMO) mandate valued at approximately Rs. 825 crore (USD 91 million) from a leading global pharma major.
Read More
Sai Life Sciences to Recruit 700+ Professionals in FY27
Updated : 2 months, 1 week ago IST
Hyderabad (Telangana) [India], February 20: Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India's leading integrated contract research, development and manufacturing organizations (CRDMOs), today announced plans to hire 700+ scientific, technical, and management professional
Read More
Akums Delivers Strong Q3 FY26 Performance with 14.8% Revenue Growth and 21
Updated : 2 months, 1 week ago IST
New Delhi [India], February 14: Akums Drugs & Pharmaceuticals Ltd., India's Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the third quarter of FY26.
Read More
Akums Reports Q2 FY26 Results; Strengthens International Presence
Updated : 6 months, 1 week ago IST
New Delhi [India], November 14: Akums Drugs & Pharmaceuticals Ltd., India's Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the second quarter of FY26.
Read More
Sai Life Sciences to Recruit 200 Scientists in November
Updated : 6 months, 2 weeks ago IST
Hyderabad (Telangana) [India], November 11: Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India's fastest-growing Contract Research, Development & Manufacturing Organizations (CRDMO), today announced plans to recruit 200 scientists in November 2025 to serve the growing deman
Read More
Sai Life Sciences Set to Double Process R&D Capacity with New Facility in
Updated : 7 months ago IST
Hyderabad (Telangana) [India], October 28: Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), one of India's fastest growing Contract Research, Development, and Manufacturing Organizations (CRDMO), today announced the groundbreaking for a new CMC Process R&D Center at its integrated R&D
Read More
Sai Life Sciences Opens Dedicated Facility for Veterinary APIs in Bidar, I
Updated : 7 months, 3 weeks ago IST
Hyderabad (Telangana) [India], September 19: Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredie
Read More
Akums Reports Q1 FY26 with 19% YoY Adj EBITDA Growth; Achieves 1,000 DCGI
Updated : 9 months, 2 weeks ago IST
New Delhi [India], August 9: Akums Drugs and Pharmaceuticals Ltd., India's largest contract development and manufacturing organization (CDMO), has announced its consolidated financial results for the quarter ended June 30, 2025. This quarter continued to display strong performance with healt
Read More
Indian CRDMOs benefiting from diversification by global pharmaceutical com
Updated : 11 months ago IST
Indian CRDMOs (Contract Research and Development and Manufacturing Organizations) are seeing growing interest from global pharmaceutical companies, according to a recent report by Jefferies.
Read More
Zydus to Enter Global Biologics CDMO Business Plans to Acquire Agenus' U.S
Updated : 11 months, 3 weeks ago IST
New Jersey [US]/ Ahmedabad (Gujarat) [India], June 3: Zydus Lifesciences Ltd. (including its subsidiaries/affiliates, hereafter referred to as "Zydus) today announced its entry into the global biologics contract development and manufacturing organization (CDMO) business through its plan to a
Read More
Akums Reports Q4 FY25 with 12.4% Revenue Growth, FY25 Adj. EBITDA Remained
Updated : 12 months ago IST
New Delhi [India], May 27: Akums Drugs and Pharmaceuticals Ltd., India's largest contract development and manufacturing organization (CDMO), has announced its consolidated financial results for the quarter and fiscal year ending March 31, 2025. The fourth quarter marked a significant rebound
Read More